- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT05606809
Sammenligning av poeng for tidlig hjerneskadevurdering ved innleggelse på intensivavdeling etter hjertestans (AfterROSC2)
Even in patients with successful return of spontaneous circulation (ROSC), outcome after cardiac arrest remains poor. The overall in-hospital survival rate widely varies both worldwide and across communities, from 1 to 4 folds according to circumstances of arrest and post-resuscitation interventions. Several studies have already shown that early interventions performed after ROSC, such as treatment of the cause, targeted temperature management, optimal hemodynamic management and extra-corporeal life support in selected patients, could improve the outcome in post-cardiac arrest patients. However, the decision process regarding the allocation of these resources, in parallel with the management of patients' proxies, remains a complex challenge for physicians facing these situations. Consequently, several prediction models and scores have been developed in order to stratify the risk of unfavorable outcome and to discriminate the best candidates for post-resuscitation interventions. Overall, several scores exist, but external validation are lacking and direct comparisons are needed to assess relative interest of scoring systems. Indeed, establishing the optimal scoring system is crucial, for optimal treatment allocation and appropriate information to relatives.
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Studietype
Registrering (Antatt)
Kontakter og plasseringer
Studiekontakt
- Navn: Jean Baptiste Lascarrou, MD, PhD
- Telefonnummer: +33240087376
- E-post: jeanbaptiste.lascarrou@chu-nantes.fr
Studer Kontakt Backup
- Navn: Alain Cariou, MD, PhD
- E-post: alain.cariou@aphp.fr
Studiesteder
-
-
-
Massy, Frankrike
- Rekruttering
- Hopital Jacques Cartier
-
Ta kontakt med:
- Wulfran Bougouin
- E-post: wulfran.bougouin@gmail.com
-
Neuilly-sur-Seine, Frankrike
- Rekruttering
- Clinique Ambroise Paré
-
Ta kontakt med:
- Guillaume Geri
- E-post: ggeri92@gmail.com
-
Paris, Frankrike
- Rekruttering
- APHP, Cochin
-
Ta kontakt med:
- Alain Cariou
- E-post: alain.cariou@aphp.fr
-
Versailles, Frankrike
- Rekruttering
- CH Versailles
-
Ta kontakt med:
- Marine Paul
- E-post: mpaul@ch-versailles.fr
-
-
Pays de Loire
-
Nantes, Pays de Loire, Frankrike
- Rekruttering
- CHU Nantes
-
Ta kontakt med:
- Jean Baptiste Lascarrou
- E-post: jeanbaptiste.lascarrou@chu-nantes.fr
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
This is an observational, prospective, multicentric prognostic study. The study period is 3 years, and investigators plan to include 4500 patients in 20 ICUs in France.
For all patients included, medical history, clinical data, paraclinical results and outcome (at hospital discharge and at 3 months, including modified Rankin score) will be prospectively collected by local investigator, according to an electronical CRF.
Beskrivelse
Inclusion Criteria:
- all adult patients, major, admitted to intensive care after cardiac arrest (after both in and out-of hospital cardiac arrest),
- comatose (defined by Glasgow score ≤ 8) on admission,
Exclusion Criteria:
- cardiac arrest occurring intra-hospital,
- minor patient,
- major patient under guardianship,
- protected persons,
- prior inclusion in the study
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Observasjonsmodeller: COHORT
- Tidsperspektiver: PROSPECTIVE
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Determination of Area Under Curve of Cerebral Admission Hospital Prognosis (CAHP) Score at intensive care unit admission
Tidsramme: Intensive Care Unit Admission (Usually 3 hours after cardiac arrest
|
Determination of AUC for CAHP score as compare to Utstein style criteria. CAHP score range from 0 to 300 with higher score indicates poorer prognosis |
Intensive Care Unit Admission (Usually 3 hours after cardiac arrest
|
Samarbeidspartnere og etterforskere
Sponsor
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 2022-A01811-42
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
IPD-planbeskrivelse
Sharing of IPD will be possible upon request to steering committee of the AfterROSC Network after approval of the project by ethics committee.
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .